PALO ALTO, Calif., Oct. 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR)
will showcase the company's interventional oncology solutions at
the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla. The Varian interventional oncology
portfolio encompasses cryo and microwave ablation systems, as well
as embolization microspheres.
"Varian is deeply committed to the ongoing development of
innovative treatment solutions for clinicians offering ablation and
embolization services to patients," said David Chen, vice president, Interventional
Oncology Solutions, Varian. "These solutions are an important
pillar of patient care and together with our clinical partners we
are moving closer to creating a world without fear of cancer."
The Varian solutions on display at the Clinical Interventional
Oncology event include:
- Cryocare SL™ System and family of
CryoProbes™ designed to deliver high-performance
cryoablation technology for a number of malignant and benign
conditions
- MicroThermX® microwave ablation systems
- Portfolio of microsphere products for treating arteriovenous
malformations and hypervascular tumors
-
- Embozene® Microspheres
- Oncozene® Microspheres
- Velocity 4.0 with RapidSphere™, a module for
Y90 Selective Internal Radiation
Therapy (SIRT) dosimetry analysis
WHERE: Booths # 300 & 302, CIO Symposium, Miami, Fla.
WHEN: Friday, October 11, 2019
through Sunday, October 13, 2019
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 9,200 employees across 70 countries keep
the patient and our clinical partners at the center of our thinking
as we power new victories in cancer care. Because, for cancer
patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow @VarianMedSys
on Twitter.
Press Contact
Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-highlights-interventional-oncology-solutions-at-cio-symposium-300933265.html
SOURCE Varian